Login / Signup

Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer.

Ammu V V V Ravi KiranGarikapati Kusuma KumariPraveen Thaggikuppe Krishnamurthy
Published in: Investigational new drugs (2021)
Preliminary results revealed that pioglitazone adjunacy with celecoxib may be an effective chemo-preventive agent against NNK induce NSCLC.
Keyphrases
  • small cell lung cancer
  • photodynamic therapy
  • combination therapy
  • single cell
  • cancer therapy
  • squamous cell carcinoma
  • radiation therapy
  • locally advanced
  • brain metastases
  • rectal cancer